# A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:

> **NCT02065479** · PHASE4 · COMPLETED · sponsor: **University of Florida** · enrollment: 65 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Prasugrel
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT02065479
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2019-04-22
- **Final completion:** 2019-04-22
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02065479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02065479, "A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02065479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*